Selected research
Industry Research
Cardiovascular Diagnostic Testing Industry Research Report 2026
Market perspective
The global Cardiovascular Diagnostic Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cardiovascular Diagnostic Testing is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cardiovascular Diagnostic Testing is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cardiovascular Diagnostic Testing include Abbott Laboratories, BD, bioMérieux, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche, PerkinElmer, Siemens AG and Tosoh Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cardiovascular Diagnostic Testing market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cardiovascular Diagnostic Testing Market by Company
Abbott Laboratories
BD
bioMérieux
Bio-Rad Laboratories
Danaher Corporation
F. Hoffmann-La Roche
PerkinElmer
Siemens AG
Tosoh Corporation
Thermo Fisher Scientific
Cardiovascular Diagnostic Testing Segment by Type
Fibrinogen Test
Angiotensin Test
Serum Uric Acid Test
Lipoprotein Test
Cardiovascular Diagnostic Testing Segment by Application
Laboratory Testing Facilities
Point-of-care Testing Facilities
Cardiovascular Diagnostic Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Diagnostic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Diagnostic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Diagnostic Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cardiovascular Diagnostic Testing manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cardiovascular Diagnostic Testing by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cardiovascular Diagnostic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fibrinogen Test
- Angiotensin Test
- Serum Uric Acid Test
- Lipoprotein Test
Applications
- Laboratory Testing Facilities
- Point-of-care Testing Facilities
Companies covered
- Abbott Laboratories
- BD
- bioMérieux
- Bio-Rad Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche
- PerkinElmer
- Siemens AG
- Tosoh Corporation
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cardiovascular Diagnostic Testing Market Size (2021-2032)
- 2.2.2 Global Cardiovascular Diagnostic Testing Sales (2021-2032)
- 2.2.3 Global Cardiovascular Diagnostic Testing Market Average Price (2021-2032)
- 2.3 Cardiovascular Diagnostic Testing by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Fibrinogen Test
- 2.3.3 Angiotensin Test
- 2.3.4 Serum Uric Acid Test
- 2.3.5 Lipoprotein Test
- 2.4 Cardiovascular Diagnostic Testing by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Laboratory Testing Facilities
- 2.4.3 Point-of-care Testing Facilities
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cardiovascular Diagnostic Testing Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cardiovascular Diagnostic Testing Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Cardiovascular Diagnostic Testing Revenue of Manufacturers (2021-2026)
- 3.4 Global Cardiovascular Diagnostic Testing Average Price by Manufacturers (2021-2026)
- 3.5 Global Cardiovascular Diagnostic Testing Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cardiovascular Diagnostic Testing, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cardiovascular Diagnostic Testing, Product Type & Application
- 3.8 Global Manufacturers of Cardiovascular Diagnostic Testing, Established Date
- 3.9 Global Cardiovascular Diagnostic Testing Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Cardiovascular Diagnostic Testing Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 BD
- 4.2.1 BD Company Information
- 4.2.2 BD Business Overview
- 4.2.3 BD Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BD Cardiovascular Diagnostic Testing Product Portfolio
- 4.2.5 BD Recent Developments
- 4.3 bioMérieux
- 4.3.1 bioMérieux Company Information
- 4.3.2 bioMérieux Business Overview
- 4.3.3 bioMérieux Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 bioMérieux Cardiovascular Diagnostic Testing Product Portfolio
- 4.3.5 bioMérieux Recent Developments
- 4.4 Bio-Rad Laboratories
- 4.4.1 Bio-Rad Laboratories Company Information
- 4.4.2 Bio-Rad Laboratories Business Overview
- 4.4.3 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Product Portfolio
- 4.4.5 Bio-Rad Laboratories Recent Developments
- 4.5 Danaher Corporation
- 4.5.1 Danaher Corporation Company Information
- 4.5.2 Danaher Corporation Business Overview
- 4.5.3 Danaher Corporation Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Danaher Corporation Cardiovascular Diagnostic Testing Product Portfolio
- 4.5.5 Danaher Corporation Recent Developments
- 4.6 F. Hoffmann-La Roche
- 4.6.1 F. Hoffmann-La Roche Company Information
- 4.6.2 F. Hoffmann-La Roche Business Overview
- 4.6.3 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Product Portfolio
- 4.6.5 F. Hoffmann-La Roche Recent Developments
- 4.7 PerkinElmer
- 4.7.1 PerkinElmer Company Information
- 4.7.2 PerkinElmer Business Overview
- 4.7.3 PerkinElmer Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PerkinElmer Cardiovascular Diagnostic Testing Product Portfolio
- 4.7.5 PerkinElmer Recent Developments
- 4.8 Siemens AG
- 4.8.1 Siemens AG Company Information
- 4.8.2 Siemens AG Business Overview
- 4.8.3 Siemens AG Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Siemens AG Cardiovascular Diagnostic Testing Product Portfolio
- 4.8.5 Siemens AG Recent Developments
- 4.9 Tosoh Corporation
- 4.9.1 Tosoh Corporation Company Information
- 4.9.2 Tosoh Corporation Business Overview
- 4.9.3 Tosoh Corporation Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Tosoh Corporation Cardiovascular Diagnostic Testing Product Portfolio
- 4.9.5 Tosoh Corporation Recent Developments
- 4.10 Thermo Fisher Scientific
- 4.10.1 Thermo Fisher Scientific Company Information
- 4.10.2 Thermo Fisher Scientific Business Overview
- 4.10.3 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Product Portfolio
- 4.10.5 Thermo Fisher Scientific Recent Developments
5 Global Cardiovascular Diagnostic Testing Market Scenario by Region
- 5.1 Global Cardiovascular Diagnostic Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cardiovascular Diagnostic Testing Sales by Region: 2021-2032
- 5.2.1 Global Cardiovascular Diagnostic Testing Sales by Region: 2021-2026
- 5.2.2 Global Cardiovascular Diagnostic Testing Sales by Region: 2027-2032
- 5.3 Global Cardiovascular Diagnostic Testing Revenue by Region: 2021-2032
- 5.3.1 Global Cardiovascular Diagnostic Testing Revenue by Region: 2021-2026
- 5.3.2 Global Cardiovascular Diagnostic Testing Revenue by Region: 2027-2032
- 5.4 North America Cardiovascular Diagnostic Testing Market Facts & Figures by Country
- 5.4.1 North America Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 5.4.3 North America Cardiovascular Diagnostic Testing Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cardiovascular Diagnostic Testing Market Facts & Figures by Country
- 5.5.1 Europe Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 5.5.3 Europe Cardiovascular Diagnostic Testing Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cardiovascular Diagnostic Testing Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cardiovascular Diagnostic Testing Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cardiovascular Diagnostic Testing Market Facts & Figures by Country
- 5.7.1 South America Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 5.7.3 South America Cardiovascular Diagnostic Testing Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cardiovascular Diagnostic Testing Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cardiovascular Diagnostic Testing Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cardiovascular Diagnostic Testing Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cardiovascular Diagnostic Testing Sales by Type (2021-2032)
- 6.1.1 Global Cardiovascular Diagnostic Testing Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Cardiovascular Diagnostic Testing Sales Market Share by Type (2021-2032)
- 6.2 Global Cardiovascular Diagnostic Testing Revenue by Type (2021-2032)
- 6.2.1 Global Cardiovascular Diagnostic Testing Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cardiovascular Diagnostic Testing Revenue Market Share by Type (2021-2032)
- 6.3 Global Cardiovascular Diagnostic Testing Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cardiovascular Diagnostic Testing Sales by Application (2021-2032)
- 7.1.1 Global Cardiovascular Diagnostic Testing Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Cardiovascular Diagnostic Testing Sales Market Share by Application (2021-2032)
- 7.2 Global Cardiovascular Diagnostic Testing Revenue by Application (2021-2032)
- 7.2.1 Global Cardiovascular Diagnostic Testing Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cardiovascular Diagnostic Testing Revenue Market Share by Application (2021-2032)
- 7.3 Global Cardiovascular Diagnostic Testing Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cardiovascular Diagnostic Testing Value Chain Analysis
- 8.1.1 Cardiovascular Diagnostic Testing Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cardiovascular Diagnostic Testing Production Mode & Process
- 8.2 Cardiovascular Diagnostic Testing Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cardiovascular Diagnostic Testing Distributors
- 8.2.3 Cardiovascular Diagnostic Testing Customers
9 Global Cardiovascular Diagnostic Testing Analyzing Market Dynamics
- 9.1 Cardiovascular Diagnostic Testing Industry Trends
- 9.2 Cardiovascular Diagnostic Testing Industry Drivers
- 9.3 Cardiovascular Diagnostic Testing Industry Opportunities and Challenges
- 9.4 Cardiovascular Diagnostic Testing Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst